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1–3 weeks, although for smaller volumes the retina reattached within a matter of days. The optimal
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following the surgery, it was possible to serially monitor the injection site and retinal bleb through fundus
photography. Light microscopy demonstrates the distribution of stable, viable RPE cells in the subretinal
space up to 6 months. The transplantation technique developed for the dog is atraumatic and free from
any major surgical or clinical complications. It can be readily used to deliver cells or fluids to localized
regions of the subretinal space.
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Posterior Segment Approach for Subretinal Transplantation
or Injection in the Canine Model
Maria E. Verdugo,* Julie Alling,* Eliot S. Lazar,† Manuel del Cerro,†‡ Jharna Ray,*
and Gustavo Aguirre*
*James A. Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853
Departments of †Ophthalmology and ‡Neurobiology and Anatomy, University of Rochester School of Medicine,
Rochester, NY 14642

A posterior segment approach for cell transplantation or injection into the subretinal space of the dog has
been developed. Controlled penetration to the subretinal space was achieved using a 29-gauge injection
cannula, either blunted or with a 30° sharpened bevel, and partially ensheathed with moveable plastic tubing.
Depending on the injection volume used, the retina detached, and the fluid was reabsorbed within 1–3
weeks, although for smaller volumes the retina reattached within a matter of days. The optimal injection
volume used was between 100 and 150 µl, or two injections of 55 µl each. By ophthalmoscopy following
the surgery, it was possible to serially monitor the injection site and retinal bleb through fundus photography.
Light microscopy demonstrates the distribution of stable, viable RPE cells in the subretinal space up to 6
months. The transplantation technique developed for the dog is atraumatic and free from any major surgical
or clinical complications. It can be readily used to deliver cells or fluids to localized regions of the subretinal
space.
Key words: Animal model; Dog; Posterior segment; Retinal pigment epithelial transplantation; Subretinal
injection; Retinitis pigmentosa

INTRODUCTION

(19), monkey (10), and rabbit (12). Typicaly, these studies have involved delivering dissociated cell suspensions, sheets, or patches of RPE into the subretinal
space.
The transplantation studies in the experimental models have, as their ultimate application, the use of similar
treatment strategies in human patients. Primary diseases
of the RPE in humans with secondary photoreceptor
dysfunction or degeneration would be amenable to transplantation of normal cells or direct in situ delivery of
vectors to transfer the normal cDNA and correct the underlying genetic defect. Dysfunction of RPE cells has
been implicated in many, frequently untreatable, retinal
diseases including age-related macular degeneration.
Additionally, recently described mutations in genes expressed exclusively in the RPE of humans and animals
[e.g., RPE65 (1,23), cellular retinaldehyde binding protein (CRALBP) (24) and retinol dehydrogenase (27)]
make the specific treatment of this cell layer a therapeutic imperative.
Experimental studies have demonstrated that photoreceptor degeneration can be prevented or delayed in sev-

Intraocular transplantation of reginal pigment epithelial (RPE) cells provides the prospect of restoring normal function to this cell layer in individuals having primary RPE dysfunction or degeneration, or where there
is a photoreceptor abnormality secondary to an RPE defect. It also can be used to transplant genetically modified cells to either replace the function of a mutant gene
or to deliver trophic factors to the interphotoreceptor
space, which can promote the survival of diseased visual
cells. The general surgical techniques for injection or
transplantation into the subretinal space that are directed
towards the treatment of retinal degenerative diseases
have been undergoing constant evolution. During the
last two decades, numerous investigators have transplanted RPE cells into the subretinal space of normal
eyes, as well as into the eyes of experimental animals
with retinal degenerations (10,18,22). The RPE transplantation has been done in several animal models such
as rat (18), rabbit (21), monkey (10), and miniature pig
(14), including xenografting of human RPE cells into rat
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eral ways. For example, transplantation of healthy RPE
cells into the subretinal space of RCS rats with photoreceptor degeneration secondary to a primary RPE defect
resulted in the functional survival of the host photoreceptors (15,20). Similarly, intraocular injection of basic
fibroblast growth factor or other cytokines delayed the
photoreceptor degeneration in dystrophic RCS rats, and
rescued photoreceptors in the light-damage rat model
(8,16). Injection into the subretinal space of genetically
modified cells to produce the desired trophic factors, recombinant viral vectors, or recombinant proteins could
ensure prolonged availability of the particular substance
lacking or deficient in the host photoreceptors or RPE
cells. Delivery of the appropriate factors to diseased visual cells may thus provide a therapeutic benefit in a
variety of currently untreatable diseases.
For surgical intervention of the subretinal space,
three different approaches have been used previously:
anterior trans-vitreal (7,14,21,26), posterior trans-scleral
(18,26), and open sky (10). Lazar and del Cerro (17)
developed a posterior injection technique in the rat that
is complication free, allows controlled penetration of the
subretinal space, and the placement of the graft is directly visualized through the pupil. This approach appeared of value for use in experimental animals such as
the dog because it reduced the need for expensive and
extensive instrumentation required by the anterior approach and, as well, avoided potential traumatic injury
to the lens. In this study we report the modification of
the posterior segment approach for use in dogs to deliver
dissociated cells or soluble products to the subretinal
space. These modifications were required because in the
dog the globe is placed deeply in the orbit, surgical exposure is limited, and the sclera, conjunctiva, and periocular tunics are much thicker than in the rat.
MATERIALS AND METHODS
Experimental Animals and Anesthesia
A total of 15 healthy normal adult dogs, either beagles or crossbred, were used in the studies. All experimental procedures adhered to the guidelines of the
ARVO Resolution on Use of Animals in Ophthalmic
and Vision Research. The dogs were sedated by intramuscular injection of acepromazine maleate (0.1 mg/kg)
administered with atropine sulfate (0.04 mg/kg), and anesthetized by the intravenous injection of ketamine hydrochloride (2 mg/kg) and diazepam (0.2 mg/kg). To
maintain anesthesia, the dogs were intubated and kept at
a surgical plane of anesthesia with halothane (1.5–
2.5%); the dose of halothane was adjusted depending
on the size of the dog, tidal volume, and frequency of
respiration. Three dogs had bilateral subretinal injections
of India ink and 12 dogs had subretinal injections of
cultured and dissociated cells. Depending on the study,
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injection volumes ranged between 10 and 200 µl; these
volumes were well within the limits tolerated by the eye
as the vitreous volume of the normal adult dog eye
ranges between 2.5 and 3.2 ml (4). Of the group receiving injections of cultured and dissociated cells, two dogs
had RPE autografts from cells collected from the fellow
enucleated eye and 10 received allografts (RPE cells or
choroidal fibroblasts) of cells obtained from various canine donors; eight dogs received bilateral injections and
two received unilateral injections. Note that with the exception of one dog that received subretinal injection of
RPE cells in one eye and choroidal fibroblasts in the
other eye (Table 1, animal #7), all of the remaining dogs
had injections of RPE cells. No attempts were made to
tissue type the donors and recipients to optimize the
match and avoid potential host vs. graft reaction. Details
of the experimental animals and protocols are summarized in Table 1.
Donor Cell Harvest and Preparation of RPE
for Transplantation
Eyes from normal dogs were obtained from other investigators at the end of their studies and were used as
donors for the allografts. All eyes were collected in icechilled Ca2+/Mg2+-free Puck’s saline F (0.127 M NaCl,
3.82 mM KCl, 1.261 mM Na2HPO4, 0.61 mM KH2PO4,
0.1 mM EDTA) containing antibiotics (penicillin, streptomycin, and gentamycin). For autologous transplantation surgery, RPE cells were harvested from one enucleated eye, processed in the same manner as allograft
cells, and transplanted into the fellow eye. The RPE
cells from donors eyes (allograft or autograft) were harvested and cultured using the method of Ray et al. (25).
Cells were dissociated by repeated trypsinization, rinsed
twice with 15% fetal bovine serum (FBS; Atlanta Biologicals, Norcross, GA) containing Dulbecco’s modified
Eagle medium [DMEM, with high glucose (4500 mg/L):
L-glutamine, pyridoxine hydrochloride without sodium
pyruvate or sodium bicarbonate] (Life Technologies,
Gaithersburg, MD), and plated at a seeding density of
2–3 × 105 cells/35-mm dish. Cells were grown in
DMEM containing 15% FBS, 2.5% glutamine, and 1%
amphotericin B (Life Technologies) and maintained in a
humidified atmosphere at 37°C in the presence of 95%
air/5% CO2. At confluence cells were passaged (1:3 ratio), and first passage cells (P1) were grown until they
reached to approximately 70% confluency.
For transplantation, the 70% confluent P1 cells were
dissociated with 0.25% trypsin, washed two times with
DMEM, and resuspended in DMEM for injection. Cell
viability was determined using the trypan blue (Sigma,
St. Louis, MO) exclusion test (5). Briefly, 10 µl of cell
suspension was mixed with 40 µl of 0.4% trypan blue,
kept at room temperature for 2–5 min, then a 12 µl ali-
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quot was placed in a Neubauer Hemocytometer slide
chamber and counted for the blue and the colorless cells.
Colorless cells, which excluded trypan blue, were indicative of live cells, while blue cells were dead; in general,
the percentage of dead cells was between 7% and 8%.
The numbers of cells and subretinal volumes injected
are detailed in Table 1.
Delivery System and Transplantation Procedure
Prior to anesthesia and surgery, the pupils were
dilated with 1% tropicamide (Alcon Laboratories,
Fort Worth, TX), 1% atropine sulfate (Optopics Laboratories, Fairton, NJ), and 2.5% phenylephrine hydrochloride (Henry Schein, Florham Park, NJ). To obtain the
best possible visualization during surgery, the dog’s
head was fixed with a vacuum pack immobilizer and
positioned under a high-resolution operating microscope. Throughout the surgery aseptic conditions were
followed.
The delivery system consisted of a custom made 29gauge cannula (Popper & Sons Inc., New Hyde Park,
NY), partially ensheathed with a tight plastic tubing, and
connected to a Kloehn microsyringe (Kloehn Ltd., Brea,
CA) by a 0.38-mm-diameter polyethylene tubing (Becton Dickinson and Company, Sparks, MD), and a 29gauge blunt adapter needle (Kloehn Ltd., Brea, CA). For
injection volumes less than 50 µl, we used a 50-µl syringe; for greater volumes a 200-µl syringe was used.
The sheath used on the cannula was made from the same
0.38-mm polyethylene tubing, and exposed the 3–4 mm
of the tip, thus limiting the depth of penetration. The
length of the sheath was adjusted on the basis of the dog’s
age and estimated scleral thickness to allow the cannula
to reach subretinal space without penetrating the retina.
Such penetration could cause damage to the retina and
vitreous, forming holes or retinal tears that can leak
transplanted cells or injected fluids into the vitreous cavity. In the first seven surgeries, the 30° sharpened beveled end of the cannula was used; in subsequent surgeries, the rounded blunt end was used to avoid accidental
penetration of the retina. Figure 1 is a schematic representation of the injection instruments and placement of
the cannula in the subretinal space.
To expose the transplantation site, a Barraquer wire
eyelid retractor was used followed by a lateral canthotomy and a fornix-based conjunctival peritotomy. The
eye was rotated ventrally, exposing the superior rectus
muscle, and a 4-0 Dermalon suture (Davis-Geck, Danbury, CT) was placed around the muscle for stabilization. A focal conjunctival peritotomy was made 15–17
mm behind the corneo–scleral junction, and bleeding
was controlled by pinpoint cautery. A one third scleral
flap was dissected with a 45° K-Sharp knife (Katena
Products Inc., Denville, NJ) to provide a window at the

Figure 1. (A) Illustration of the delivery system used for subretinal injections. The 29-gauge cannula has a polyethylene
tubing sheath near the tip to control the depth of penetration.
A 0.38-mm-diameter polyethylene tube connects the cannula
to the injection syringe adapter (not shown). The beveled and
blunt orientations of the cannula are shown. (B) Placement of
the beveled point of the injection cannula in the subretinal
space. Depth of penetration is controlled by the plastic sheath
around the cannula, and the direction of fluid flow is illustrated by the arrows.

transplantation site. The thin floor of the flap formed a
translucent membrane through which the choroid could
be visualized. The blunt tipped or beveled cannula was
manually inserted through the floor of the scleral flap
and gently rotated in order to penetrate to the desired
depth, and then the injection was carried out. In general,
resistance to the needle penetration was present primarily at the scleral surface and, to a much lesser extent, at
the RPE/Bruch’s membrane interface. Successful penetration of this latter layer allowed the easy release of
the injection volume with gentle manual pressure of the
syringe plunger. Depending of the study, the volume injected varied between 10 and 200 µl/injection site, and
there was minimal reflux if the injection rate was slow,
gradual, and volumes less than 150 µl were used. The
superior half of the eye was favored because in the dog
this area has a nonpigmented RPE overlying the reflective tapetum lucidum. As a result, it is easier to examine
and photograph the injection site(s). However, we have
done the same procedure in the inferior retinal quadrants
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with no variation in the method or in the results (see
Table 1 for details).
Following the injection, the scleral flap was sutured
with nonabsorbable 6-0 Dermalon (Davis-Geck, Danbury, CT) to identify the external site of injection once
the eye was enucleated, and the canthotomy was closed
with 6-0 Dermalon nonabsorbable sutures in a simple
interrupted pattern. Immediately following surgery, 2
mg of triamcinolone acetonide (Kenalog-10; BristolMyers Squibb Company, Princeton, NJ) was injected
subconjunctivally one time to prevent postoperative inflammation. The postoperative treatment consisted of
oral Clavamox (11 mg/kg), topical ophthalmic antibiotic/
steroid ointment and solution (neomycin, polymyxin B
sulfate, and dexamethasone, Altana Inc., Melville, NY),
administered 2 times a day for 1 week. Other topical
medications (e.g., atropine sulfate 1%, gentamicin, or
prednisolone acetate 1%) were used in the postoperative
period if there was ocular inflammation (atropine and
prednisolone acetate) or if conjunctivitis was unresponsive to the topical antibiotic/steroid medications used.
Clinical Evaluations
The injection site was evaluated immediately after
surgery using the operating microscope and a noncontact
Super Field fundus lens (Volk, Mentor, OH). Following
surgical intervention, animals were routinely examined
at several points during the course of the study. In general, dogs were examined during the first week, weekly–
biweekly for the first 4–6 weeks, and monthly thereafter. In each case, the clinical exam included evaluation
of the anterior segment and a complete funduscopic examination using a Keeler binocular indirect ophthalmoscope (Keeler Instruments, Broomall, PA) and a Volk
2.2 pan-retinal fundus lens. Direct ophthalmoscopy and
biomicroscopy were used when necessary. Fundus photography was performed using Kodachrome 25 film
(Eastman Kodak Company, Rochester, NY) and a Kowa
RC-2 fundus camera (Kowa Company, Ltd., Japan) was
used directly or indirectly through the Volk 2.2 or Nikon
20 diopter lenses.
Histological Procedures
The dogs were euthanatized with an overdose of sodium pentobarbital administered intravenously, and the
eyes were immediately enucleated and all adhering extraocular muscles removed. The anterior segment was
removed with a single-edge razor blade that hemisected
the eye behind the lens, approximately 4–5 mm behind
the limbus. The eyecup was fixed with chilled 4% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for a
minimum of 2–6 h, rinsed with the phosphate buffer,
trimmed, and dehydrated through graded ethanol con-
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centrations before processing for embedding in JB-4
(Sigma). The embedded retinal strips were sectioned at
3 µm with tooled steel knives in an AO Spencer 820
Microtome; after flattening in a 68–80°F water bath, the
sections were transferred to a slide, heated (120°F for
5–10 min), and stained with methylene blue/Azure II.
The sections were mounted with Permount (Fisher Scientific, Fair Lawn, NJ), coverslipped, and evaluated and
photographed with a Zeiss Axioplan light microscope
(Zeiss, Inc., White Plains, NY).
RESULTS
Clinical Assessment
The injection procedure was well tolerated in the 12
eyes that received subretinal cell injections. Postsurgical
observation periods ranged from 0 days to 24.5 weeks
with a median survival time of 5 weeks (Table 1). Mild
conjunctivitis was noted in five eyes (three dogs), and a
small subconjunctival hemorrhage was present in one
eye of a different animal; these generally resolved
within 1–2 weeks following surgery. Transient, lowgrade anterior uveitis and vitreal flare was found in four
eyes (two dogs), and vitreal condensations or strands
were noted unilaterally in four other dogs. Cataracts did
not develop as a result of the surgical manipulation or
injection.
Because most of the injections were made through
the tapetum lucidum in the superior quadrant, the hallmark finding of the injection was the instantaneous focal
color change in the tapetal layer as the result of penetration of the injection cannula. This lesion appeared black,
presumably the result of a focal change in the cellular
organization of this layer, and this color change was evident ophthalmoscopically regardless of whether the injection volume was media or cells (data not shown). The
appearance of the fundus immediately following the injection was dependent on the volume of fluid injected.
Apart from the focal tapetal puncture wound, injection
volumes of 10 µl were not visible clinically. Small blebs
resulted from volumes of 50 µl, and these usually resorbed in 2–3 days (Fig. 2). Medium-sized blebs resulted from injections of 100 µl, which resorbed within
1 week. Retinal folds were associated with the peripheral border of small and medium-sized blebs, and these
flattened out with fluid resorption from the subretinal
space. Larger injection volumes (e.g., 150 and 200 µl)
resulted in very large blebs that occupied one quarter to
one half of the subretinal expanse and, in some cases,
resulted in an increased intraocular pressure immediately after injection.
The appearance of the injection site was dependent
on the number of RPE cells injected, their level of
pigmentation, which is very variable in the dog, and
whether the cells were dispersed throughout the subreti-

SUBRETINAL RPE TRANSPLANTATION/INJECTION

321

Table 1. Details of the Animals and Methods Used in the Subretinal Injection Studies

Volume/Injection

No. of Injections
and Site

Total No. RPE Cells/Eye

Postinjection Period

India ink
#1/OD
#1/OS

10 µl
10 µl

4 (2 sup./2 inf.)
4 (2 sup./2 inf.)

—
—

0 days
0 days

#2/OD
#2/OS

10 µl
10 µl

2 (sup.)
2 (sup.)

—

0 days
0 days

#3/OD
#3/OS

40 µl
40 µl

2 (1 sup./1 inf.)
2 (1 sup./1 inf.)

—
—

0 days
0 days

10 µl

2 (1 sup./1 inf.)

4.5 × 105

5.1 weeks

55 µl

2 (sup.)

1 × 10

16 weeks

100 µl
200 µl

1 (sup.)
1 (sup.)

1.4 × 105
1.4 × 105

0 days
0 days

#7/OD
#7/OS

125 µl
125 µl

2 (sup.)
2 (sup.)

#8/OD
#8/OS

10 µl
10 µl

2 (sup.)
2 (sup.)

3.8 × 105
5.2 × 105

3.2 weeks
3.2 weeks

#9/OD
#9/OS

10 µl
20 µl

2 (1 sup./1 inf.)
2 (1 sup./1 inf.)

1.5 × 106
1.5 × 106

4 weeks
4 weeks

#10/OD
#10/OS

40 µl
50 µl

2 (sup.)
2 (sup.)

4.6 × 106
4.6 × 106

5 weeks
5 weeks

#11/OD

150 µl

1 (sup.)

1 × 106

5 weeks

#12/OD

10 µl

2 (1 sup./1 inf.)

6.5 × 10

6 weeks

#13/OD
#13/OS

15 µl
15 µl

2 (1 sup./1 inf.)
2 (1 sup./1 inf.)

5

9.5 × 10
9.5 × 105

7.1 weeks
7.1 weeks

$14/OD
#14/OS

40 µl
50 µl

2 (1 sup./1 inf.)
2 (1 sup./1 inf.)

5.6 × 105
5.4 × 105

21 weeks
21 weeks

#15/OD
#15/OS

25 µl
25 µl

2 (1 sup./1 inf.)
2 (1 sup./1 inf.)

5 × 105
5 × 105

Animal No./Eye

RPE autografts
#4/OS
#5/OD
RPE (or CF) allografts
#6/OD
#6/OS

5

1 × 106
1 × 106(CF)

5

3 weeks
3 weeks

24.5 weeks
24.5 weeks

OD: right eye; OS: left eye. sup.: superior quadrant; inf.: inferior quadrant. CF: choroidal fibroblasts.

nal bleb or were clustered at the site of injection. When
using low injection volumes and a high concentration of
RPE cells, the cells formed a darkly pigmented cluster
in the subretinal space; larger volumes with similar concentration of cells dispersed the cells over a larger area
of the subretinal space and effectively eliminated the
cellular aggregates found with the lower volumes (Fig.
2, compare A, B with C, D). Moreover, the presence of
hemorrhage, either subretinal (six eyes of five dogs) or
vitreal (one eye), influenced the appearance of the injection site. In all cases, the blood was resorbed within 1–2
weeks and was never larger than the example illustrated
in Figure 2A. Serial examination of the eyes during the

postinjection period did not demonstrate changes in the
size or appearance of the transplant in animals that received either autografts or allografts, and there was no
retinal or choroidal edema or inflammation, which could
have resulted from an immune-mediated response to the
transplanted cells.
In 5 of the 12 eyes, pigmented cells were found on
the retinal surface or posterior vitreous. In three of the
eyes, the cells formed very small aggregates in the posterior vitreal cortex or along strands of vitreous. In one
case, a focal cluster of RPE cells accumulated on the
retinal surface (Fig. 3). The presence of these cells on
the retinal surface or vitreous indicated partial or full
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Figure 2. Fundus photographs of experimental animals at different postinjection intervals. (A, B) Dog #13 at 2 days (A) and 7.1
weeks (B) following injection of RPE cells (allograft) in a 15 µl volume. At the early time point there is a darkly pigmented
subretinal lesion resulting from the injection. Surrounding the transplanted cells is a zone of subretinal edema and hemorrhage
(arrows), which disappears by the 7.1 week time point without any alteration in the surrounding retina. (C, D) Dog #5 at 2 days
(C) and 2 weeks (D) following injection of autologous RPE cells in a 55 µl volume. Two injection sites are visible on the second
postoperative day, and these are located beneath a fluid bleb (C, small arrows). By 2 weeks the fluid has been resorbed and the
retina is flat.

retinal penetration by the injection cannula. Serial examination and photography of these eyes indicated that the
small vitreal pigment cell clusters did not change in size
or extend into the retinal surface and/or vitreous in the
animals with postinjection survival periods of 3, 5, 21,
and 24.5 weeks. In contrast, the one eye that received
allografts of choroidal fibroblasts (subretinal injection
with secondary vitreal extension) showed by 3 weeks
postinjection retinal traction that resulted from fibroblast
proliferation along the vitreal cortex and retinal surface
(data not shown).

Histologic Results
In developing the surgical technique, we initially injected India ink as a marker. Injections resulted in the
separation of the retina from the pigment epithelium and
the accumulation of injected fluid volume in the subretinal space. There was minimal damage to the retina adjacent to the injection site (Fig. 4A, B). In the absence of
retinal penetration or reflux around the scleral puncture,
the size of the subretinal bleb was dependent on the volume of fluid injected. Similar results were obtained in
short-term injections of RPE cells suspended in DMEM
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Figure 3. Fundus photograph and photomicrograph of the right eye of dog #7, 3 weeks after the injection of RPE cells. (A)
Accidental penetration of the retina resulted in a preretinal cluster of pigmented cells (large open arrow) that obscures the underlying
retina and vessels; retinal folds (arrowheads) are at the margins of the pigment cell cluster. A smaller group of pigmented cells
(small arrows) is located over the posterior vitreous over two retinal vessels. (B) Histological section showing the cluster of RPE
cells attached to the inner retinal surface. Note that the pigment cells remain well circumscribed without extension into the retina
or vitreous (130×).

using larger fluid volumes. The separation of the retina
from the RPE occurred at the tip of the photoreceptor
outer segments, and caused minimal to no retinal damage either at the injection site or in adjacent areas (Fig.
5A, B). Because of the larger fluid volumes used, and
loss of cells during tissue processing, we could not identify the transplanted cells in the subretinal space.
With postinjection intervals of 3 weeks or longer,
cells were readily identified in the subretinal space,
which had the cytologic characteristics of RPE and
likely were of donor origin. Very rarely the cells formed
a partial monolayer located between the host RPE and
retina (Fig. 6A). More frequently, single or isolated
clusters of RPE cells were found subretinally in the
previously detached regions; again, these cells were interposed between the host RPE cells and the photoreceptors (Fig. 6B, C). Because cell marking studies were not
carried out, it was not possible to determine if the transplanted cells replaced the host RPE cells on Bruch’s
membrane. In parallel with the clinical observations, we
did not find vasculitis of the preretinal vessels nor cellular infiltration of mononuclear cells in the choroid, either
at the transplant site or elsewhere, that could represent
a rejection response to the transplant. The two eyes receiving RPE autografts showed the same response as
those that received allografts.
The most common surgical complication was penetration of the retina by the injection cannula. At these
sites the transplanted RPE cells formed cellular aggregates attached to the retinal surface (Fig. 3B). These cell
clusters remained aggregated and did not extend into the
adjacent retina. In cases where the retina was penetrated,

but the injection cannula was withdrawn without injection, a focal retinal scar formed, often with limited fibrous connective tissue that extended from the overlying
choroid (Fig. 7). The retina adjacent to these focal scars
was normal.
DISCUSSION
This study demonstrates the development of a posterior approach for subretinal injection or cell transplantation in the canine model. The procedure is atraumatic
and has minimal morbidity; long-term observation of
those animals that survived for nearly 6 months has indicated no major complications, either in the immediate
postoperative period or later. This procedure is potentially adaptable for use in other large animal models
(e.g., primates and cats), which are commonly used in
ophthalmic research studies.
Studies requiring access to the subretinal space have
used either anterior or posterior approaches. The anterior
approach is favored by surgeons working with nonrodent eyes, because direct visualization of the placement
of the injection cannula in the subretinal space allows
for greater success in placing the transplanted cells
(3,6,21). In addition to the greater need for surgical instrumentation and dexterity, the major limitations of the
anterior approach include damage to the photoreceptors
and nerve fiber layer and the presence of a retinal hole
that can leak RPE cells into the vitreous where they
might eventually support proliferative vitreoretinopathy.
The posterior or transcleral approach has been successfully used in RPE transplantation studies to prevent
photoreceptor degeneration in RCS rats (18,19). Wong-
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Figure 4. Photomicrographs of an eye immediately following
the subretinal injection of 10 µl of India ink. (A) The fluid (*)
is confined to the subretinal space with a gradual elevation of
the retina. (B) The edge of the subretinal bleb shows the minimal damage that has occurred away from the injection site.
The India ink is confined to the subretinal space, and the vitreous (V) is free of injection product. (A = 250×).

pichedchai et al. (26) compared results of RPE transplantation in rabbits using the internal and external approaches and found that the external approach resulted
in better grafts, although the lack of direct visualization
was a limitation.
Lazar and del Cerro (17) have developed a precise
means of accessing the subretinal space of rats for transplantation or injection. Their method is based on the
principle of using a preset stop to limit penetration of
the needle, and direct visual control through the dilated
pupil of the host eye. The eye is maintained in the primary gaze position, and, because of the optical properties of the rat eye, one can directly monitor the penetration of the needle into the subretinal space and the
formation of the bleb through the operating microscope.
Such a method has the added advantage of allowing
real-time photography or video to document the transplantation procedure.

Figure 5. Photomicrographs of an eye immediately following
the injection of 100 µl of RPE cells in DMEM. (A) The fluid
(*) has separated the retina from the RPE, but no transplanted
RPE cells are visible at the edge of the subretinal bleb. (B)
Away from the detachment site, the retina is intact. V, vitreous
cavity; PR, photoreceptor layer; ONL, outer nuclear layer;
INL, inner nuclear layer. (A = 250×; B = 500×).

We have modified this technique for use in a larger
species such as the dog, and have found it to provide
consistent results once the technique is mastered. However, the lack of direct visualization during the injection
procedure is a major limitation. Unlike the rodent,
whose readily mobile and anteriorly placed eye allows
access to the posterior sclera, the dog eye is large and
deeply set in the orbit. In order to access the posterior
surface of the globe for injections, the eye must be rotated away from the site of injection. Thus, the injections
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Figure 6. Photomicrographs of dogs following subretinal injection of RPE cells, which survived for periods of 3 weeks or longer.
(A) Monolayer of transplanted cells (arrows) is present in the subretinal space (*) between the host RPE and the retina. The normal
photoreceptor integrity indicates that the separation of the retina is a processing artifact. (B, C) Transplanted RPE cells (white
arrows) located in the subretinal space adjacent to the host RPE. (A = 250×; B, C = 400×).

Figure 7. Photomicrograph illustrating a focal retinal scar following penetration by the injection cannula. Connective tissue
extends from the choroid and fills the retinal defect (250×).

are made by “feel” (i.e., sensing the resistance to the
needle penetration as it goes first through the base of the
scieral flap and subsequently through Bruch’s membrane). The lack of direct observation resulted in the
puncture of the retina in the initial surgeries even when
the plastic sheath around the injection cannula was set

to limit the depth of needle penetration. Subsequent surgeries used the blunt end of the injection cannula for
tissue penetration, and, together with the plastic sheath
near the tip of the injection cannula, this prevented the
puncture of the retina as the needle entered the subretinal space.
Even when the retina is penetrated and RPE cells
gained access to the vitreous cavity, we found no cellular proliferation or secondary complications in the animals. Although labeling to identify cell division was not
used, the RPE cell cluster that formed immediately after
the injection remained stable in size, did not extend into
the adjacent retina or vitreous cortex, and did not show
any evidence of proliferative activity and retinal traction, such as was produced when autologous choroidal
fibroblasts were used. This situation appears quite different from the human, where vitreal RPE proliferation
results in retinal membranes and proliferative vitreoretinopathy (11,13). One possible difference is that we used
normal eyes from healthy young adult animals for these
studies, and there was no evidence of concurrent retinal
or vitreal disease prior to the injection or transplantation
procedure. In contrast, proliferative vitreoretinopathy
develops in older human eyes that have abnormalities of
the vitreous, retinal detachment, or other retinal surgeries and, as a result, may be predisposed for this devastating complication (9,13).
We have used a large range of injection volumes with
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or without RPE cells. A volume of 10 µl resulted in a
nondetectable retinal bleb that covered a minimal retinal
expanse. Volumes of 150–200 µl were much more effective in spreading through the subretinal space but, especially for injections of 200 µl, resulted in transient
increases in intraocular pressure. If such large volumes
are required, then decompression of the globe by anterior chamber paracentesis could be readily performed
following the subretinal injection. From these results, we
estimate that a volume of 50–75 µl injected into the
subretinal space in each of four quadrants (supero nasal
and temporal; infero nasal and temporal) would be required to distribute the fluid over most of the subretinal
expanse. Such a volume would likely result in a complete serous retinal detachment. However, based on prior
observations in dogs with total serous detachments secondary to acute hypertension, reattachment of the retina
without secondary complications would be expected to
occur within 1–2 weeks following the injection (2).
The distribution of transplanted RPE cells within the
subretinal space was more dependent on the injection
volume than the cell concentration. Low volumes resulted in deeply pigmented subretinal RPE cell foci,
while larger volumes showed more uniform distribution
of small numbers of RPE cells. In this case, cells were
found throughout the interphotoreceptor space adjacent
to the RPE layer. Very rarely was a monolayer of donor
RPE cells present in the subretinal space, and, additionally, we did not identify the presence of transplanted
pigmented RPE cells that had replaced donor cells on
Bruch’s membrane. Although donor cell labeling was
not done before transplantation, a prerequisite for identifying donor vs. host cells, similar studies using normal
or β-glucuronidase (GUSB)-corrected RPE cells transplanted into GUSB-deficient recipients have shown the
same results (Verdugo et al., unpublished results). That
is, the donor cells do not fully repopulate Bruch’s membrane, but are located as single or multiple cell clusters
in the interphotoreceptor space. In regards to the transplantation of RPE cells, the surgical approach we have
developed would be more applicable to returning to the
subretinal space cells that could secrete trophic factors
or act as enzyme pumps to release to the extracellular
environment enzymes that are deficient in the host RPE
cell layer. Additionally, the method is also applicable
for the subretinal delivery of fluids or viral vectors. It
will require further development of the technique to
have the transplanted RPE cells replace, to a large extent, the host population of cells.
Zhang and Bok (28) have shown that transplanted
RPE cells in rats that have incompatible MHC haplotypes with the host are slowly rejected even though there
is no histologically evident acute immune rejection. In
this study, however, whether the transplanted cells were
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located in the subretinal space or accidentally injected
into the vitreous cavity, there was no evidence of immune rejection of RPE cells. Neither was there evidence
of retinal perivasculitis, edema, or cellular infiltration,
either at the transplantation site or further away. This
lack of response to RPE allografts was similar to what
was observed in the two RPE autographs. Because no
effort was made to tissue type the donor and host to
maximize tissue compatibility, it is possible that the lack
of response could indicate that in the dog model the
transplant sites were immunologically privileged.
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